Sharing GJB2/GJB6 genetic test information with family members

Journal of Genetic Counseling

Volumn 16, Issue 3, 2007, Pages 313-324

  Blase, Terri ^a,e   Martinez, Ariadna ^b   Grody, Wayne W ^c   Schimmenti, Lisa ^d   Palmer, Christina G S ^b,c,f  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e ADVOCATE CHRIST MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Connexin 26; Cx26; Deafness; Disclosure; Family; Genetic counseling; Genetic testing; GJB2; Hearing loss

Indexed keywords

CONNEXIN 26;

ADULT; ARTICLE; CHILD PARENT RELATION; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; GENE DELETION; GENETIC DISORDER; GENETIC SCREENING; HEARING LOSS; HUMAN; INFANT; INTERPERSONAL COMMUNICATION; MALE; PRESCHOOL CHILD; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW;

ADAPTATION, PSYCHOLOGICAL; CHILD, PRESCHOOL; CONNEXINS; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; MALE; PRIVACY; SELF DISCLOSURE; VARIATION (GENETICS);

EID: 34249952403     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-006-9066-z     Document Type: Article

References (38)

1. Abe, S., Usami, S., Shinkawa, H., Kelley, P. M., & Kimberling, W. J. (2000). Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet, 37, 41-43.
2. Anderlik, M. R., & Lisko, E. A. (2000). Medicolegal and ethical issues in genetic cancer syndromes. Semin Surg Oncol, 18, 339-346.
3. Arnos, K. S., Israel, J., & Cunningham, M. (1991). Genetic counseling of the deaf. Medical and cultural considerations. Ann NY Acad Sci, 630, 212-222.
4. Azaiez, H., Chamberlin, G. P., Fischer, S. M., Welp, C. L., Prasad, S., Taggart, R. R., et al. (2004). GJB2: The spectrum of deafness-causing allele variants and their phenotype. Human Mutation, 24, 305-311.
5. Billings, K. R., & Kenna, M. A. (1999). Causes of pediatric sensorineural hearing loss: Yesterday and today. Arch Otolaryngol, 125, 517-521.
6. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A, 116, 11-19.
7. Cryns, K., Orzan, E., Murgia, A., Huygen, P. L. M., Moreno, F., del Castillo, I., et al. (2004). A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet, 41, 147-154.
8. del Castillo, I., Villamar, M., Moreno-Pelayo, M. A., del Castillo, F. J., Alvarez, A., Telleria, D., et al. (2002). A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. New Engl J Med, 346, 243-249.
9. Denoyelle, F., Lina-Granade, G., Plauchu, H., Bruzzone, R., Chaib, H., Levi-Acobas, F., et al. (1998). Connexin 26 gene linked to a dominant deafness. Nature, 393, 319-320.
10. Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., Garabedian, E. N., et al. (1999). Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: Implications for genetic counselling. Lancet, 353, 1298-1303.
11. Estivill, X., Fortina, P., Surrey, S., Rabionet, R., Melchionda, S., D'Agruma, L., et al. (1998). Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet, 351, 394-398.
12. Flick, U. (1998). An introduction to qualitative research. London: Sage.
13. Gorlin, R. J., Toriello, H. V., & Cohen Jr., M. M. (1995). Hereditary hearing loss and its syndromes. New York: Oxford University Press, Inc.
14. Green, G. E., Scott, D. A., McDonald, J. M., Woodworth, G. G., Sheffield, V. C., & Smith, R. J. (1999). Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA, 281, 2211-2216.
15. Henneman, L., Kooij, L., Bouman, K., & ten Kate, L. P. (2002). Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families. Am J Med Genet, 110, 324-331.
16. Hone, S. W., & Smith, R. J. H. (2002). Medical evaluation of pediatric hearing loss: Laboratory, radiographic, and genetic testing. Otolaryng Clin N Am, 35, 751-764.
17. Jacobs, L. M. (1989). A deaf adult speaks out. Washington, D.C.: Gallaudet University.
18. Kenna, M. A., Wu, B. L., Cotanche, D. A., Korf, B. R., & Rehm, H. L. (2001). Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head & Neck Surgery, 127, 1037-1042.
19. Kenneson, A., Van Naarden Braun, K., & Boyle, C. (2002). GJB2 (connexin 26) variants and non-syndromic sensorineural hearing loss: A huge review. Genet Med, 4, 258-274.
20. Marlin, S., Garabedian, E. N., Roger, G., Moatti, L., Matha, N., Lewin, P., et al. (2001). Connexin 26 gene mutations in congenitally deaf children: Pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg, 127, 927-933.
21. McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med, 6, 503-509.
22. Mesters, I., Ausems, M., Eichhorn, S., & Vasen, H. (2005). Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A retrospective exploratory study. Fam Cancer, 4, 163-167.
23. Morell, R. J., Kim, H. J., Hood, L. J., Goforth, L., Friderici, K., Fisher, R., et al. (1998). Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med, 339, 1500-1505.
24. Morton, N. E. (1991). Genetic epidemiology of hearing impairment. Ann NY Acad Sci, 630, 16-31.
25. Nance, W. E. (2003). The genetics of deafness. Ment Retard Dev Disabil Res Rev, 9, 109-119.
26. Ormond, K. E., Mills, P. L., Lester, L. A., & Ross, L. F. (2003). Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet, 119C, 70-77.
27. Pallares-Ruiz, N., Blanchet, P., Mondain, M., Claustres, M., & Roux, A.-F. (2002). A large deletion including most of GJB6 in recessive non syndromic deafness: A digenic effect? European J Hum Genet, 10, 72-76.
28. Palmer, C. G. S., Martinez, A., Fox, M., Crandall, B., Shapiro, N., Telatar, M., et al. (2003). Genetic testing and the early hearing detection and intervention process. Volta Rev, 103, 371-390.
29. Pandya, A., Arnos, K. S., Xia, X. J., Welch, K. O., Blanton, S. H., Friedman, T. B., et al. (2003). Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med, 5, 295-303.
30. Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., et al. (2003). How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet, 119C, 78-86.
31. Schimmenti, L. A., Martinez, A., Fox, M., Crandall, B., Shapiro, N., Telatar, M., et al. (2004). Genetic testing as part of the Early Hearing Detection and Intervention (EHDI) process. Genet Med, 6, 521-525.
32. Smith, K., Zick, C. D., Mayer, R. N., & Botkin, J. R. (2002). Voluntary disclosure of BRCA1 mutation test results. Genet Test, 6, 89-92.
33. Smith, R. (2001). Mutation screening for deafness: More than simply another diagnostic test. Arch Otolaryngol, 127, 941-942.
34. Smith, S. (1991). Recurrence risks. Ann NY Acad Sci, 630, 203-211.
35. Sorenson, J. R., Jennings-Grant, T., & Newman, J. (2003). Communication about carrier testing within hemophilia A families. Am J Med Genet C, 119, 3-10.
36. Wagner Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: A cancer risk assessment program's experience. Am J Med Genet C, 119, 11-18.
37. Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western J Nurs Res, 19, 71-81.
38. Zelante, L., Gasparini, P., Estivill, X., Melchionda, S., D'Agruma, L., Govea, N., et al. (1997). Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet, 6, 1605-1609.